OKYO
OKYO
NASDAQ · Biotechnology

Okyo Pharma Ltd

$1.53
-0.05 (-3.16%)
As of Mar 29, 10:45 PM ET ·
Financial Highlights (FY 2025)
Revenue
9.01M
Net Income
-596,230
Gross Margin
28.8%
Profit Margin
-6.6%
Rev Growth
+12.0%
D/E Ratio
0.77
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 28.8% 28.8% 28.8%
Operating Margin -6.6% -6.1% -7.2%
Profit Margin -6.6% -5.9% -6.5%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 9.01M 9.02M 8.76M
Gross Profit 2.60M 2.60M 2.52M
Operating Income -598,038 -548,941 -631,893
Net Income -596,230 -528,269 -565,775
Gross Margin 28.8% 28.8% 28.8%
Operating Margin -6.6% -6.1% -7.2%
Profit Margin -6.6% -5.9% -6.5%
Rev Growth +12.0% +12.6% +22.9%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 28.04M 27.36M 27.28M
Total Equity 36.63M 39.85M 39.13M
D/E Ratio 0.77 0.69 0.70
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -746,119 -716,524 -642,558
Free Cash Flow -600,890 -503,274 -433,552